Maybe a few mil value Nothing was proven yet and nobody Wants to give the fund as of now They should have done financing for This long period. The mgmt is incompetent These shares are not even restricted and can be dilluted any day now
Re: Volcano Post# 29988 The 321 million shares was for the patents to discharge the debt. So how does discharging all debt with shares valued 5 times where we are now do as you say. Phase 1 costs Very little. They would only need 5-10 million. They could almost partner up for this drug. Not sure if you understand this drug but it is almost identical to etoposide with only one small side chain variation that allows for its effectiveness against multi drug resistant cancers with no current treatments. This thing is about as slam dunk as you can get in bio this early in the process. The preclinical safety and pharmacokinetics was identical to etoposide and it will Get bought out in phase 1 IMO.